RAD51D
Treatment
Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy. Drug Des Devel Ther. 2018;12:1501–9. [revistamedicinadelaboratorio.es]
Prevention
Genome maintenance mechanisms for preventing cancer. Nature. 2001 May 1;411(6835):366–74. DOI: 10.1038/35077232 Walsh CS. Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy. [revistamedicinadelaboratorio.es]